303 related articles for article (PubMed ID: 28472490)
1. In vitro susceptibility of Sporothrix brasiliensis: Comparison of yeast and mycelial phases.
Sanchotene KO; Brandolt TM; Klafke GB; Poester VR; Xavier MO
Med Mycol; 2017 Nov; 55(8):869-876. PubMed ID: 28472490
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.
Borba-Santos LP; Rodrigues AM; Gagini TB; Fernandes GF; Castro R; de Camargo ZP; Nucci M; Lopes-Bezerra LM; Ishida K; Rozental S
Med Mycol; 2015 Feb; 53(2):178-88. PubMed ID: 25394542
[TBL] [Abstract][Full Text] [Related]
3. In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
Song Y; Li S; Shi Y; Zhao L; Cui Y; Yao L; Zhen Y; Chen R; Cui Y
Braz J Microbiol; 2021 Mar; 52(1):81-90. PubMed ID: 32557246
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil.
Brilhante RS; Rodrigues AM; Sidrim JJ; Rocha MF; Pereira SA; Gremião ID; Schubach TM; de Camargo ZP
Med Mycol; 2016 Mar; 54(3):275-9. PubMed ID: 26591009
[TBL] [Abstract][Full Text] [Related]
5. Sporothrix schenckii complex in Iran: Molecular identification and antifungal susceptibility.
Mahmoudi S; Zaini F; Kordbacheh P; Safara M; Heidari M
Med Mycol; 2016 Aug; 54(6):593-9. PubMed ID: 26933207
[TBL] [Abstract][Full Text] [Related]
6. Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Boechat JS; Pereira SA; de Sá Machado AC; Viana PG; Almeida-Paes R; Zancopé-Oliveira RM; Gremião IDF; de Oliveira MME
Braz J Microbiol; 2021 Mar; 52(1):135-143. PubMed ID: 32617836
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats.
Han HS; Kano R; Chen C; Noli C
Vet Dermatol; 2017 Feb; 28(1):156-e32. PubMed ID: 28133872
[TBL] [Abstract][Full Text] [Related]
8. Feline sporotrichosis: a case series of itraconazole-resistant Sporothrix brasiliensis infection.
Nakasu CCT; Waller SB; Ripoll MK; Ferreira MRA; Conceição FR; Gomes ADR; Osório LDG; de Faria RO; Cleff MB
Braz J Microbiol; 2021 Mar; 52(1):163-171. PubMed ID: 32388779
[TBL] [Abstract][Full Text] [Related]
9. Clotrimazole is highly effective in vitro against feline Sporothrix brasiliensis isolates.
Gagini T; Borba-Santos LP; Messias Rodrigues A; Pires de Camargo Z; Rozental S
J Med Microbiol; 2017 Nov; 66(11):1573-1580. PubMed ID: 28984226
[TBL] [Abstract][Full Text] [Related]
10. Clinical and epidemiological aspects of feline sporotrichosis caused by Sporothrix brasiliensis and in vitro antifungal susceptibility.
Maschio-Lima T; Marques MDR; Lemes TH; Brizzotti-Mazuchi NS; Caetano MH; de Almeida BG; Bianco LM; Monteiro RC; Rodrigues AM; de Camargo ZP; Siqueira JPZ; de Almeida MTG
Vet Res Commun; 2021 Dec; 45(4):171-179. PubMed ID: 34129207
[TBL] [Abstract][Full Text] [Related]
11. Chemical and cytotoxic analyses of brown Brazilian propolis (Apis mellifera) and its in vitro activity against itraconazole-resistant Sporothrix brasiliensis.
Waller SB; Peter CM; Hoffmann JF; Picoli T; Osório LD; Chaves F; Zani JL; de Faria RO; de Mello JR; Meireles MC
Microb Pathog; 2017 Apr; 105():117-121. PubMed ID: 28219829
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of diphenyl diselenide alone and in combination with itraconazole against Sporothrix brasiliensis.
Poester VR; Mattei AS; Mendes JF; Klafke GB; Ramis IB; Sanchotene KO; Xavier MO
Med Mycol; 2019 Apr; 57(3):328-331. PubMed ID: 29924365
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of isolates of Sporothrix schenckii to amphotericin B, itraconazole, and terbinafine: comparison of yeast and mycelial forms.
Kohler LM; Soares BM; de Assis Santos D; Da Silva Barros ME; Hamdan JS
Can J Microbiol; 2006 Sep; 52(9):843-7. PubMed ID: 17110976
[TBL] [Abstract][Full Text] [Related]
14. The Current Status of Feline Sporotrichosis in Malaysia.
Siew HH
Med Mycol J; 2017; 58(3):E107-E113. PubMed ID: 28855477
[TBL] [Abstract][Full Text] [Related]
15. Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis.
Almeida-Paes R; Brito-Santos F; Figueiredo-Carvalho MHG; Machado ACS; Oliveira MME; Pereira SA; Gutierrez-Galhardo MC; Zancopé-Oliveira RM
Mem Inst Oswaldo Cruz; 2017 May; 112(5):376-381. PubMed ID: 28443986
[TBL] [Abstract][Full Text] [Related]
16. Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility.
Indoung S; Chanchayanon B; Chaisut M; Buapeth KO; Morteh R; Jantrakajorn S
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36130102
[TBL] [Abstract][Full Text] [Related]
17. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance.
Almeida-Paes R; Oliveira MME; Freitas DFS; Valle ACFD; Gutierrez-Galhardo MC; Zancopé-Oliveira RM
Med Mycol; 2017 Jul; 55(5):507-517. PubMed ID: 27771622
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina.
Córdoba S; Isla G; Szusz W; Vivot W; Hevia A; Davel G; Canteros CE
Mycoses; 2018 Jul; 61(7):441-448. PubMed ID: 29500853
[TBL] [Abstract][Full Text] [Related]
19. Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole.
Borba-Santos LP; Gagini T; Ishida K; de Souza W; Rozental S
J Med Microbiol; 2015 Apr; 64(Pt 4):415-422. PubMed ID: 25681323
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B, alone or followed by itraconazole therapy, is effective in the control of experimental disseminated sporotrichosis by Sporothrix brasiliensis.
Ishida K; de Castro RA; Borba Dos Santos LP; Quintella LP; Lopes-Bezerra LM; Rozental S
Med Mycol; 2015 Jan; 53(1):34-41. PubMed ID: 25306202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
